Abbott, Alere, Roche, and Others Receive FDA Clearances in May

Jun 08, 2018

|

NEW YORK (360Dx) – Abbott, its subsidiary Alere, and Roche were among companies that received US Food and Drug Administration clearances in May for their in vitro diagnostic tests, according to the FDA website.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Abbott, Alere, Roche, and Others Receive FDA Clearances in May

To read the full story....

Breaking News

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

Agendia Settles Allegations of Medicare Fraud for $8.25M

Noridian Aligns With Palmetto on Single-Gene, Multi-Gene PGx Test Coverage

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

Sysmex Nabs Japan Approval for Automated Hematology Analyzer to Diagnose Malaria

Centogene Gets Emergency Use Authorization for PCR-Based Coronavirus Test

Featured White Papers

Development of a Metagenomics-based Pathogen-Detection Assay for SARS-CoV-2 Research

What's Popular?

HHS Guidance Could Undermine SARS-CoV-2 Surveillance Testing Efforts

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

Automation Helps COVID-19 Testing Scale Up, but Supply Chain Disruptions Persist

Yale, NBA Validating RNA Extraction-Free Saliva Test for Coronavirus

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

Sponsorships